Safety, immunogenicity and infectivity of new live attenuated influenza vaccines

Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus

(2015) Larisa Rudenko et al.   Expert Review of Vaccines

Advances in the development of influenza virus vaccines

(2015) Florian Krammer et al.   NATURE REVIEWS DRUG DISCOVERY

Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh

(2015) Justin R. Ortiz et al.   VACCINE

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers

(2015) Irina Isakova-Sivak et al.   Human Vaccines & Immunotherapeutics

Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis

(2015) Aronrag Meeyai et al.   PLOS MEDICINE

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

(2015) Ernest Milián et al.   Biomed Research International

Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms

(2014) Catherine J Luke et al.   Expert Review of Vaccines

Development of live attenuated influenza vaccines against pandemic influenza strains

(2014) Kathleen L Coelingh et al.   Expert Review of Vaccines

A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response

(2014) Kawsar R. Talaat et al.   JOURNAL OF INFECTIOUS DISEASES

Structural Stability of Influenza A(H1N1)pdm09 Virus Hemagglutinins

(2014) H. Yang et al.   JOURNAL OF VIROLOGY

Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine

(2014) Larisa Rudenko et al.   PLoS One

Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers

(2014) Jacco Heldens et al.   VACCINE

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine

(2014) Tara M. Babu et al.   VACCINE

Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans

(2014) A. Morokutti et al.   VACCINE

Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine

(2014) Prasad S Kulkarni et al.   Human Vaccines & Immunotherapeutics

Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines

(2014) Yang Zang et al.   Human Vaccines & Immunotherapeutics

A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus HA Protein Affects Viral Fusion, Stability and Infectivity

(2014) Christopher R. Cotter et al.   PLoS Pathogens

Vaccine-Induced Boosting of Influenza Virus-Specific CD4 T Cells in Younger and Aged Humans

(2013) Douglas V. Dolfi et al.   PLoS One

Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets

(2013) Yo Han Jang et al.   VACCINE

Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses

(2013) Marc P. Girard et al.   VACCINE

Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines

(2013) Yo Han Jang et al.   VACCINE

Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains

(2013) Yo Han Jang et al.   VACCINE

H5N1 vaccines in humans

(2013) Mariana Baz et al.   VIRUS RESEARCH

An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

(2012) Kawsar R. Talaat et al.   Influenza and Other Respiratory Viruses

Comparative Study of Influenza Virus Replication in MDCK Cells and in Primary Cells Derived from Adenoids and Airway Epithelium

(2012) N. A. Ilyushina et al.   JOURNAL OF VIROLOGY

The Contribution of Systemic and Pulmonary Immune Effectors to Vaccine-Induced Protection from H5N1 Influenza Virus Infection

(2012) Y.-F. Lau et al.   JOURNAL OF VIROLOGY

Cold-Adapted Pandemic 2009 H1N1 Influenza Virus Live Vaccine Elicits Cross-Reactive Immune Responses against Seasonal and H5 Influenza A Viruses

(2012) Y. H. Jang et al.   JOURNAL OF VIROLOGY

Engineering influenza viral vectors

(2012) Junwei Li et al.   Bioengineered

Memory T-Cell Immune Response in Healthy Young Adults Vaccinated with Live Attenuated Influenza A (H5N2) Vaccine

(2011) T. V. Chirkova et al.   Clinical and Vaccine Immunology

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference

(2011) Allyn Bandell et al.   Expert Review of Vaccines

Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection

(2011) Suzanne E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children

(2011) Daniel F. Hoft et al.   JOURNAL OF INFECTIOUS DISEASES

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

(2011) Steven Black et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities

(2011) Marie R. Griffin et al.   PLoS One

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer

(2011) Martin Friede et al.   VACCINE

Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries

(2011) Larisa Rudenko et al.   VACCINE

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

(2011) Kawsar R. Talaat et al.   VACCINE

Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17–18 February 2011

(2011) Marc P. Girard et al.   VACCINE

Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets

(2011) Koert J. Stittelaar et al.   VACCINE

Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process

(2010) Meena George et al.   BIOTECHNOLOGY AND BIOENGINEERING

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

(2010) Christopher S. Ambrose et al.   Influenza and Other Respiratory Viruses

Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials

(2010) Raburn M. Mallory et al.   PLoS One

Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells

(2010) Althaf I. Hussain et al.   VACCINE

Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice

(2009) N. Wressnigg et al.   JOURNAL OF GENERAL VIROLOGY

A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy Adults

(2009) Ruth A. Karron et al.   JOURNAL OF INFECTIOUS DISEASES

A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication‐Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1

(2009) Volker Wacheck et al.   JOURNAL OF INFECTIOUS DISEASES

Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine

(2009) Julia Romanova et al.   PLoS One

Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials

(2009) Frederick G. Hayden et al.   VACCINE

Use of MDCK cells for production of live attenuated influenza vaccine

(2009) Jonathan Liu et al.   VACCINE

Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate

(2009) Nina Wressnigg et al.   VACCINE

Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK

(2009) Philip D. Minor et al.   VACCINE

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

(2009) Kawsar R. Talaat et al.   VACCINE

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults

(2009) Ruth A. Karron et al.   VACCINE

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials)

(2008) Larisa Rudenko et al.   Influenza and Other Respiratory Viruses

Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza

(2008) J. Steel et al.   JOURNAL OF VIROLOGY

Development and characterization of a live attenuated influenza B virus vaccine candidate

(2008) Sang-Uk Seo et al.   VACCINE